---
url: https://www.servicesaustralia.gov.au/x-linked-hypophosphataemia
title: X-linked hypophosphataemia - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:42:01.329Z
source: servicesaustralia.gov.au
---
# X-linked hypophosphataemia

The PBS subsidises burosumab for patients with X-linked hypophosphataemia (XLH).

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with burosumab under the _National Health Act 1953_, section 100 for adult patients with X-linked hypophosphataemia (XLH).

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](https://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing burosumab.

## Section 100 arrangements

### Burosumab

This item is only PBS-subsidised for non-admitted patients, day admitted patients or patients on discharge who are attending:

-   an approved private hospital
-   a public hospital.

This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital provider number for the authority application.

## Treatment specifics

To be eligible for PBS-subsidised treatment with burosumab, patients must be treated by a medical practitioner identifying as at least one of the following specialists:

-   paediatric endocrinologist
-   paediatric nephrologist
-   endocrinologist
-   nephrologist.

## Authority applications

### Applying for initial treatment

Applications for initial authority approval to prescribe PBS-subsidised burosumab to treat XLH can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised burosumab to treat XLH can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
